# OnCo record alitretinoin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/alitretinoin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "alitretinoin" ;
  schema:name "Alitretinoin"@en ;
  schema:alternateName "9-cis-retinoic acid"@en, "Panretin" ;
  schema:description "Alitretinoin gel is a vitamin A derivative applied directly to Kaposi sarcoma skin lesions in people with AIDS, approved in the United States in 1999 as the first topical treatment for the disease."@en ;
  schema:url <https://onco.cc/drugs/alitretinoin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Alitretinoin> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020886>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=alitretinoin>, <https://en.wikipedia.org/wiki/Alitretinoin> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Topical retinoid gel" ;
  onco:approval "US 1999: Cutaneous lesions of AIDS-related Kaposi sarcoma (topical gel)" ;
  onco:cancers <https://onco.cc/cancers/kaposi-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/eisai/> ;
  onco:trials <https://onco.cc/trials/nct05016349/> .